Parvovirus B19 infection: Association with third-trimester intrauterine fetal death

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 107, Issue 4, 2000, Pages 476-480

  Skjöldebrand Sparre, Lottie ^a   Tolfvenstam, Thomas ^b   Papadogiannakis, Nikos ^b   Wahren, Britta ^c   Broliden, Kristina ^b   Nyman, Margareta ^a  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PARAFFIN;

ADULT; ARTICLE; CLINICAL FEATURE; DEVICE; ERYTHEMA INFECTIOSUM; FEMALE; FETUS DEATH; FETUS HYDROPS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PLACENTA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY; SWEDEN; THIRD TRIMESTER PREGNANCY; VIREMIA;

ADULT; DNA, VIRAL; FEMALE; FETAL DEATH; HUMANS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; SWEDEN;

EID: 0034101916     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb13265.x     Document Type: Article

References (32)

1. Brown KE, Anderson SM, Young NS, Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1994; 262: 114–117.
2. Porter HJ, Quantrill AM, Fleming KA. B19 parvovirus infection of myocardial cells. Lancet 1988; 1: 535–536.
3. Public Health Laboratory Service Working Party on Fifth Disease. BMJ 1990; 300:1166–1170.
4. Heegaard ED, Hornsleth A. Parvovirus: the expanding spectrum of disease. Acta Paediatr 1995; 84: 109–117.
5. Jordan JA. Identification of human parvovirus B19 in idiopathic nonimmune hydrops fetalis. Am J Obstet Gynecol 1996; 174: 37–42.
6. Morey AL, Keeling JW, Porter HJ, Fleming KA. Clinical and histopathological features of parvovirus B19 infection in the human fetus. Br J Obstet Gynaecol 1992; 99: 566–574.
7. Forouzan I. Hydrops fetalis: recent advances. Obstet Gynecol Surv 1997; 52: 130–138.
8. Sanghi A, Morgan-Capner P, Hesketh L, Elstein M. Zoonotic and viral infection in fetal loss after 12 weeks. Br J Obstet Gynaecol 1997; 104: 942–945.
9. Wright C, Hindcliffe SA, Taylor C. Fetal pathology in intrauterine death due to parvovirus B19 infection. Br J Obstet Gynaecol 1996; 103: 133–136.
10. Skjöldebrand-Sparre L, Fridell E, Nyman M, Wahren B. A prospective study of antibodies against parvovirus B19 in pregnancy. Acta Obstet Gynecol Scand 1996; 75: 336–339.
11. Wånggren K, Norman M. Evaluation of a new protocol for investigation of the cause of intrauterine fetal death. Acta Obstet Gynecol Scand 1996; 75:93.
12. Broliden K, Tolfvenstam T, Ohlsson S, Henter JI. Persistent B19 parvovirus infection in pediatric malignancies. Med Ped Oncol 1998; 31: 66–72.
13. Lundqvist A, Tolfvenstam T, Brytting M, Stolt CM, Hedman K, Broliden K. Prevalence of parvirus B19 DNA in bone marrow of patients with hematological disorders. Scand J Infect Dis 1999; 31:119–122.
14. Incerpi MH, Miller DA, Samadi R, Sttlage RH, Goodwin TM. Stillbirth evaluation: What tests are needed Am J Obstet Gynecol 1998; 178: 1121–1125.
15. De Krijger RR, van Elsacker-Niele AMW, Mulder-Stapel A et al. Detection of parvovirus B19 infection in first and second trimester fetal loss. Ped Pathol Lab Med 1998; 18: 23–34.
16. Petrikovsky BM, Baker D, Schneider E. Fetal hydrops secondary to human parvovirus infection in early pregnancy. Prenat Diagn 1996; 16: 342–344.
17. Brandenburg H, Los FJ, Cohen-Overbeek TE. A case of early intrauterine parvovirus B19 infection. Prenat Diagn 1996; 16: 75–77.
18. Levy R, Weissman A, Blomberg G, Hagay ZJ. Infection by parvovirus B19 during pregnancy: a review. Obstet Gynaecol Surv 1997; 52: 254–259.
19. Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998; 105: 174–178.
20. Lowden E, Weinstein L. Unexpected second trimester pregnancy loss due to maternal parvovirus B19 infection. South Med J 1997; 90: 702–704.
21. Wattre P, Dewilde A, Subtil D, Andreoletti L, Thirion V. A clinical and epidemiological study of human parvovirus B19 infection in fetal hydrops using PCR southern blot hybridization and chemiluminescence detection. J Med Virol 1998; 54: 140–144.
22. Mielke G, Enders G. Late onset of hydrops fetalis following intrauterine parvovirus B19 infection. Fetal Diagn Ther 1997; 12: 40–42.
23. Cassinotti P, Schultze D, Wieczorek K, Schönenberger R, Siegl G. Parvovirus B19 infection during pregnancy and development of hydrops fetalis despite the evidence for pre-existing anti-B19 antibody: how reliable are serological results Clin Diagn Virol 1994; 2: 87–94.
24. Frickhofen N, Abkowitz JL, Safford M et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 1990; 113: 926–933.
25. Faden H, Gary GW Jr, Anderson LJ. Chronic parvovirus infection in a presumably immunologically healthy woman. Clin Infect Dis 1992; 15: 595–597.
26. Lundqvist A, Tolfvenstam T, Bostic J, Söderlund M, Broliden K. Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow. Scand J Infect Dis 1999; 31: 11–16.
27. Pillay D, Patou G, Griffiths PD, Rees L. Secondary parvovirus B19 infection in an immunocompromised child. Pediatr Infect Dis J 1991; 10: 623–624.
28. Kurtzman GJ, Cohen B J, Field AM et al. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invesrt 1989; 84: 1114–1123.
29. Smoleniec JS, Pillai M, Caul EO, Usher J. Subclinical transplacental parvovirus B19 infection: an increased fetal risk. Lancet 1994; 343: 1100–1101.
30. Wright C. Detection of parvovirus B19 in macerated fetal tissue using in situ hybridisation. J Clin Pathol 1998; 51: 262.
31. Naides SJ, Weiner CP. Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to fetal parvovirus B19 infection. Prenat Diagn 1989; 9: 105–114.
32. Selbing A, Josefsson A, Dahle LO, Lindgren R. Parvovirus B19 infection during pregnancy treated with high-dose intravenous gammaglobulin. Lancet 1995; 345: 660–661.